François Asperti-Boursin

410 citations
9 papers · 294 indexed · h-index 7

François Asperti-Boursin

9 papers receiving 293 citations

Peers

François Asperti-Boursin
Comparison fields: 5 of 62
  • Immunology 198
  • Immunology and Allergy 31
  • Oncology 83
  • Small Animals 18
  • Epidemiology 46
Replace Nutan Srivastava with:
Nutan Srivastava Canada
Eva Bachtanian Germany
P. Zaech Switzerland
Marie Tourret France
Hélio J. Crespo Portugal
Åse Björstad Sweden
Gilberto E. Hernandez United States
Daniel Sherer United States
Katarzyna M. Skrzypczynska United States
Verena Supper Austria
François Asperti-Boursin relative to Nutan Srivastava Canada Nutan Srivastava's profile →
Citations per field
00.5×
Nutan Srivastava · 1×
Citations per year

Countries citing papers authored by François Asperti-Boursin

Since Specialization
Citations

This map shows the geographic impact of François Asperti-Boursin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Asperti-Boursin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Asperti-Boursin more than expected).

Fields of papers citing papers by François Asperti-Boursin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Asperti-Boursin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Asperti-Boursin. The network helps show where François Asperti-Boursin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside François Asperti-Boursin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with François Asperti-Boursin Line = papers co-authored together François Asperti-Boursin links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 20142
2 20131
3 201311
4 20138
5 201116
6 201152
7 200952
8 200922
9 2007130

About François Asperti-Boursin

François Asperti-Boursin is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 9 papers that have together received 294 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Cell Adhesion Molecules Research (2 papers), Chemokine receptors and signaling (2 papers), Diffusion and Search Dynamics (2 papers), Single-cell and spatial transcriptomics (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Immunology (198 citations), Immunology and Allergy (31 citations) and Oncology (83 citations). François Asperti-Boursin has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Emmanuel Donnadieu, Georges Bismuth, Eliana Real, Alain Trautmann, Klaus Okkenhaug, Yoshihiko Tanaka, Vincenzo Di Bartolo, Bart Vanhaesebroeck, Agnès Le Bon and Kathrin Gollmer. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026